Adam Laponis Twist Bioscience Corp (TWST) insider trading activity

Adam Laponis is Chief Financial Officer of Twist Bioscience Corp. Currently has a direct ownership of 142,769 shares of TWST, which is worth approximately $3.84 Million. The most recent transaction as insider was on Nov 21, 2025, when has been sold 887 shares (Common Stock) at a price of $26.5 per share, resulting in proceeds of $23,505. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 143K

38.72% 3M change

23.1% 12M change

Total Value Held $3.84 Million

Adam Laponis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 21 2025	SELL Open market or private sale	$23,505 $26.5 p/Share	887 Reduced 0.62%	142,769 Common Stock
Nov 18 2025	BUY Grant, award, or other acquisition	-	32,648 Added 18.52%	143,656 Common Stock
Oct 30 2025	SELL Open market or private sale	$173,454 $31.44 p/Share	5,517 Reduced 4.73%	111,008 Common Stock
Oct 28 2025	BUY Grant, award, or other acquisition	-	25,000 Added 17.66%	116,525 Common Stock
Oct 09 2025	SELL Open market or private sale	$82,859 $32.92 p/Share	2,517 Reduced 2.68%	91,525 Common Stock
Oct 08 2025	SELL Open market or private sale	$93,450 $31.15 p/Share	3,000 Reduced 3.09%	94,042 Common Stock
Oct 06 2025	SELL Open market or private sale	$189,116 $32.19 p/Share	5,875 Reduced 5.71%	97,042 Common Stock

Aug 21 2025	SELL Open market or private sale	$23,831 $25.96 p/Share	918 Reduced 0.88%	102,917 Common Stock
Jul 09 2025	SELL Open market or private sale	$93,429 $38.15 p/Share	2,449 Reduced 2.31%	103,569 Common Stock
May 21 2025	SELL Open market or private sale	$27,846 $29.75 p/Share	936 Reduced 0.88%	106,018 Common Stock
Feb 21 2025	SELL Open market or private sale	$40,557 $44.18 p/Share	918 Reduced 0.83%	109,496 Common Stock
Jan 10 2025	SELL Open market or private sale	$254,628 $43.26 p/Share	5,886 Reduced 5.07%	110,096 Common Stock
Dec 04 2024	BUY Grant, award, or other acquisition	-	26,745 Added 18.74%	115,982 Common Stock
Nov 06 2024	SELL Open market or private sale	$185,536 $44.6 p/Share	4,160 Reduced 4.45%	89,237 Common Stock
Nov 04 2024	BUY Grant, award, or other acquisition	-	20,000 Added 17.64%	93,397 Common Stock
Oct 09 2024	SELL Open market or private sale	$35,789 $41.81 p/Share	856 Reduced 1.15%	73,397 Common Stock
Jul 09 2024	SELL Open market or private sale	$41,182 $48.91 p/Share	842 Reduced 1.13%	73,602 Common Stock
Apr 09 2024	SELL Open market or private sale	$18,436 $33.16 p/Share	556 Reduced 0.74%	74,444 Common Stock
Jan 08 2024	BUY Grant, award, or other acquisition	-	75,000 Added 50.0%	75,000 Common Stock

Also insider at

EAR

Eargo, Inc. Healthcare

Chief Financial Officer

Adam Laponis

Chief Financial Officer

San Jose, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TWST shares.

Notify only if

Value

Insider Trading

Get notified when an Twist Bioscience Corp insider buys or sells TWST shares.

Notify only if

Operation

Value

Type

News

Receive news related to Twist Bioscience Corp

Track Activities on TWST

Account